Sanofi Announces EMA Acceptance Of MAA Submission For Praluent
January 12, 2015 at 16:52 PM EST
Sanofi faces a steep patent cliff, but I believe Praluent will help offset the subsequent drop in revenues.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.